Advanced Bacterial Sciences secures £500,000 funding package

Lancaster University-based Advanced Bacterial Sciences (ABS) has secured a £500,000 deal to enable it to commercialise the results of its research.

ABS creates, manufactures and sells biological solutions for a range of real-world pollution and maintenance problems.

The funding has been provided by NPIF - Maven Equity Finance, which is managed by Maven Capital Partners and is a part of the Northern Powerhouse Investment Fund (NPIF).

The investment will enable ABS to commercialise its portfolio of products, sell directly to end users, as well as invest in continuous product development, patenting future technologies and scientific advances.

Headquartered at the Environment Centre, Lancaster University, the investment will also enable ABS to open a laboratory and office in Morecombe. The new location will help to reduce outsourcing of third party bacteria creation and offer a more tailored approach to its clients’ needs.

ABS will also create an innovation centre that will co-locate other complimentary start-ups and researchers to carry out their research and innovation. This centre of excellence will function as an incubator to create specialist jobs in the region, reducing the brain drain currently occurring in the local higher education institutes.

The team already has a number of product lines harnessing bacterial solutions that address pressing environmental problems. Its current investment in improvements in bacterial science ensure its products lead ‘inter alia’ to: a reduction in uric acid build-up in urinals; unblocking of grease traps and connected infrastructure; and reduction in water pollution. These unique bacterial formulas are designed to digest pollution and waste by natural means only, and so avoid the use of damaging toxic chemicals.

The scope of ABS’ bacteria solutions covers multiple large scale markets including hospitality, sanitation, water management, agriculture, property management and construction. With a range of patented bacterial formulations, ABS aims to become a trusted partner and collaborator to its stakeholders, providing various complementary solutions to address the growing markets they operate in.

The business is backed by a highly knowledgeable team, with technical expertise and skills across the sectors they operate in. Gareth Hughes, co-founder and chairman/CEO, (pictured) has a background as a corporate advisor with significant experience in low carbon enterprise, from start-ups to major public companies. He is also a founder of two capital advisory and funding firms and in this new venture, is backed by a strong and varied team across the organisation’s commercial and scientific departments.

ABS is a member of RedCAT, a scheme launched earlier this year that aims to drive Lancashire’s post-pandemic recovery with investment in the latest low carbon technologies.

Alex Rothwell, senior investment manager at Maven, said: "ABS presents environmentally-friendly solutions to global issues and the business has created and patented a range of products that have great potential market across numerous sectors.

"The highly experienced and commercially focused senior team are well placed to drive the growth ambitions of the business forward and we are delighted to support Gareth and management as they embark on a programme of expansion."

Debbie Francis, chair of the Lancashire Enterprise Partnership, added: "ABS is a perfect example of the entrepreneurial and innovative flair which we are so proud of within Lancashire. They are not only providing solutions which will allow them to access global markets, but also make a significant contribution to the Net Zero agenda.

"They were part of the Lancashire delegation to COP26 as an exemplar working within this space. ABS is a growing company providing high-quality jobs and a fitting recipient of this funding. I wish them well with their growth plans.''

• For further Lancashire business news, advice and analysis subscribe to Lancashire Business View or join the LBV Hub from just £2.50 per month. Click here to subscribe now.